Suppr超能文献

一株典型的土拉弗朗西斯菌 O 抗原的制备会得到三种糖的混合物。

A typical preparation of Francisella tularensis O-antigen yields a mixture of three types of saccharides.

机构信息

Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118, United States.

出版信息

Biochemistry. 2011 Dec 20;50(50):10941-50. doi: 10.1021/bi201450v. Epub 2011 Nov 28.

Abstract

Tularemia is a severe infectious disease in humans caused by the Gram-negative bacterium Francisella tularensis (Ft). Because of its low infectious dose, high mortality rate, and the threat of its large-scale dissemination in weaponized form, development of vaccines and immunotherapeutics against Ft is essential. Ft lipopolysaccharide (LPS), which contains the linear graded-length saccharide component O-antigen (OAg) attached to a core oligosaccharide, has been reported as a protective antigen. Purification of LPS saccharides of defined length and composition is necessary to reveal the epitopes targeted by protective antibodies. In this study, we purified saccharides from LPS preparations from both the Ft subspecies holarctica live vaccine strain (LVS) and the virulent Ft subspecies tularensis SchuS4 strain using liquid chromatography. We then characterized the fractions using high-resolution mass spectrometry and tandem mass spectrometry. Three types of saccharides were observed in both the LVS and SchuS4 preparations: two consisting of OAg tetrasaccharide repeats attached to one of two core oligosaccharide variants and one consisting of tetrasaccharide repeats only (coreless). The coreless OAg oligosaccharides were shown to contain Qui4NFm (4,6-dideoxy-4-formamido-D-glucose) at the nonreducing end and QuiNAc (2-acetamido-2,6-dideoxy-O-D-glucose) at the reducing end. Purified homogeneous preparations of saccharides of each type will allow mapping of protective epitopes in Ft LPS.

摘要

兔热病是一种由革兰氏阴性细菌弗朗西斯菌(Ft)引起的人类严重传染病。由于其感染剂量低、死亡率高,以及其在武器化形式下大规模传播的威胁,因此开发针对 Ft 的疫苗和免疫疗法至关重要。Ft 脂多糖(LPS)含有线性分级长度的聚糖成分 O-抗原(OAg),连接到核心寡糖上,已被报道为保护性抗原。纯化具有定义长度和组成的 LPS 聚糖对于揭示保护性抗体靶向的表位是必要的。在这项研究中,我们使用液相色谱法从 Ft 亚种 holarctica 活疫苗株(LVS)和毒力 Ft 亚种 tularensis SchuS4 菌株的 LPS 制剂中纯化了聚糖。然后,我们使用高分辨率质谱和串联质谱对这些级分进行了表征。在 LVS 和 SchuS4 制剂中观察到三种类型的聚糖:两种由连接到两种核心寡糖变体之一的 OAg 四糖重复组成,一种由四糖重复组成(无核心)。无核心 OAg 寡糖被证明在非还原端含有 Qui4NFm(4,6-二脱氧-4-甲酰胺-D-葡萄糖),在还原端含有 QuiNAc(2-乙酰氨基-2,6-二脱氧-O-D-葡萄糖)。每种类型的糖的纯同质制剂的纯化将允许在 Ft LPS 中绘制保护性表位。

相似文献

1
A typical preparation of Francisella tularensis O-antigen yields a mixture of three types of saccharides.
Biochemistry. 2011 Dec 20;50(50):10941-50. doi: 10.1021/bi201450v. Epub 2011 Nov 28.
7
Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
Microbiology (Reading). 2007 Sep;153(Pt 9):3141-3153. doi: 10.1099/mic.0.2007/006460-0.
8
Structural analysis of a protective epitope of the Francisella tularensis O-polysaccharide.
Biochemistry. 2012 Jul 17;51(28):5684-94. doi: 10.1021/bi201711m. Epub 2012 Jul 2.
9
Functional and structural characterization of Francisella tularensis O-antigen antibodies at the low end of antigen reactivity.
Monoclon Antib Immunodiagn Immunother. 2014 Aug;33(4):235-45. doi: 10.1089/mab.2014.0022.

引用本文的文献

1
Recent insights into Wzy polymerases and lipopolysaccharide O-antigen biosynthesis.
J Bacteriol. 2025 Apr 17;207(4):e0041724. doi: 10.1128/jb.00417-24. Epub 2025 Mar 11.
4
From the Outside-In: The Francisella tularensis Envelope and Virulence.
Front Cell Infect Microbiol. 2015 Dec 23;5:94. doi: 10.3389/fcimb.2015.00094. eCollection 2015.
7
Chemical synthesis of the outer core oligosaccharide of Escherichia coli R3 and immunological evaluation.
Org Biomol Chem. 2015 Apr 14;13(14):4321-30. doi: 10.1039/c5ob00177c. Epub 2015 Mar 12.
8
Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates.
PLoS Pathog. 2014 Oct 23;10(10):e1004439. doi: 10.1371/journal.ppat.1004439. eCollection 2014 Oct.
9
Functional and structural characterization of Francisella tularensis O-antigen antibodies at the low end of antigen reactivity.
Monoclon Antib Immunodiagn Immunother. 2014 Aug;33(4):235-45. doi: 10.1089/mab.2014.0022.
10
B-cell epitopes in GroEL of Francisella tularensis.
PLoS One. 2014 Jun 26;9(6):e99847. doi: 10.1371/journal.pone.0099847. eCollection 2014.

本文引用的文献

1
Electron transfer dissociation of milk oligosaccharides.
J Am Soc Mass Spectrom. 2011 Jun;22(6):997-1013. doi: 10.1007/s13361-011-0117-9. Epub 2011 Apr 14.
2
Tularemia vaccines: recent developments and remaining hurdles.
Future Microbiol. 2011 Apr;6(4):391-405. doi: 10.2217/fmb.11.22.
4
A two-component Kdo hydrolase in the inner membrane of Francisella novicida.
Mol Microbiol. 2010 Nov;78(4):820-36. doi: 10.1111/j.1365-2958.2010.07305.x.
7
Francisella tularensis vaccines.
Vaccine. 2009 Nov 5;27 Suppl 4:D48-51. doi: 10.1016/j.vaccine.2009.07.090.
8
Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.
Immunol Lett. 2007 Oct 15;112(2):92-103. doi: 10.1016/j.imlet.2007.07.006. Epub 2007 Aug 8.
9
New approaches to diagnosis and therapy of tularemia.
Ann N Y Acad Sci. 2007 Jun;1105:378-404. doi: 10.1196/annals.1409.017. Epub 2007 Apr 27.
10
Molecular epidemiology, evolution, and ecology of Francisella.
Ann N Y Acad Sci. 2007 Jun;1105:30-66. doi: 10.1196/annals.1409.011. Epub 2007 Apr 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验